IP Library Assignment 064492/0281
Patent Assignment
Reel/Frame 064492/0281

Assignment of Assignor's Interest

Recorded: 2023-08-04 Pages: 16
Assignor
KEDALION THERAPEUTICS, INC.
Executed: 2022-11-15
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Multi-Dose Ocular Fluid Delivery System
Application: 18/311,673 →
Publication: US 2023/0301831
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 4, 2023
From: QUINTANA, REYNALDO; IVRI, YEHUDA
To: KEDALION THERAPEUTICS, INC.
Reel/Frame 064492/0108 →
Assignment of Assignor's Interest Nov 9, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065531/0583 →
Intellectual Property Security Agreement Feb 27, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066694/0131 →
Intellectual Property Security Agreement Feb 29, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066707/0684 →
Patent Security Agreement Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
Assignment of Security Interest in Patents Previously Recorded at Reel/Frame (066694/0131) Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0655 →